SYNGR3 and head and neck cancer: Moreover, additional analyses confirm that SYNGR3 expression is high in HPV(+)OPSCC and low in HPV(−) OPSCC (Fig. 1B), suggesting that SYNGR3 is indeed a diagnostic and prognostic biomarker of head and neck cancers.